Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

NYC reception spotlights future of research and care

Three people speaking at an event on stage

Fall 2025
By Hannah White Hannah
Photography by David Chung

Dana-Farber Trustees, Pan-Mass Challenge Heavy Hitters, supporters, and friends gathered at Cure in New York City to meet Benjamin L. Ebert, MD, PhD, and engage in conversation about the path forward for Dana-Farber. Pictured with Ebert are Nobel Laureate William Kaelin, Jr., MD, and Institute Trustee, Moira Forbes, who moderated an informative discussion as part of the evening’s program. In his inaugural year as Dana-Farber’s President and CEO, Ebert shared his vision, emphasizing the Institute’s 50/50 approach to research and care. The discussion highlighted Dana-Farber’s significant impact on drug development. Amid federal funding uncertainties, the event emphasized the importance of continued support for groundbreaking advancements in cancer treatment and early detection.

, ,
Copy link
Powered by Social Snap